The head and neck cancer immune landscape and its immunotherapeutic implications

Recent clinical trials have demonstrated a clear survival advantage in advanced head and neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint blockade. These emerging results reveal that HNSCC is one of the most promising frontiers for immunotherapy research. However, further...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:JCI Insight
Main Authors: Mandal, Rajarsi, Şenbabaoğlu, Yasin, Desrichard, Alexis, Havel, Jonathan J., Dalin, Martin G., Riaz, Nadeem, Lee, Ken-Wing, Ganly, Ian, Hakimi, A. Ari, Chan, Timothy A., Morris, Luc G.T.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Clinical Investigation 2016
נושאים:
Research Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5070962/
https://ncbi.nlm.nih.gov/pubmed/27777979
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.89829
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים